Jemperli 500mg Injection (Dostarlimab) – Global Supplier & Exporter | Ernest Oncology Jemperli 500mg Injection Jemperli 500mg Injection contains Dostarlimab, an advanced immunotherapy medicine used in the treatment of certain types of endometrial cancer and other solid tumors. It belongs to the class of PD-1 immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Jemperli 500mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Jemperli 500mg Injection? Jemperli is a monoclonal antibody immunotherapy designed to treat cancers with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) characteristics. The medicine works by activating the immune system to detect and destroy cancer cells. This targeted immunotherapy helps improve treatment outcomes for patients with advanced cancers. Mechanism of Action Dostarlimab works by blocking the Programmed Death-1 (PD-1) receptor found on immune cells. Its mechanism includes: • Blocking the PD-1 immune checkpoint pathway • Enhancing immune system response against cancer cells • Restoring the body’s ability to detect and destroy tumor cells • Slowing cancer growth and progression Indications Jemperli 500mg Injection is used for the treatment of: • Endometrial Cancer with dMMR or MSI-H • Advanced or Recurrent Endometrial Cancer • Certain solid tumors with mismatch repair deficiency It is generally used when cancer has progressed after other treatments. Dosage & Administration Typical dosage guidelines: • 500 mg administered intravenously every 3 weeks • Later adjusted to 1000 mg every 6 weeks depending on treatment protocol • Given as an IV infusion in hospital or clinical settings Treatment should be administered under the supervision of an oncologist. Key Benefits of Jemperli 500mg Injection ✔ Advanced immunotherapy for cancer treatment ✔ Activates the immune system to fight cancer ✔ Effective for dMMR / MSI-H tumors ✔ Helps control tumor progression ✔ Targeted monoclonal antibody therapy Possible Side Effects Some patients may experience: • Fatigue • Nausea • Diarrhea • Skin rash • Fever • Immune-related reactions Patients should be monitored regularly during treatment. Product Specifications Product Name: Jemperli Generic Name: Dostarlimab Strength: 500 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Immunotherapy / PD-1 Inhibitor Packaging: Vial Storage: Store in refrigerator (2°C – 8°C), do not freeze Ernest Oncology supplies Jemperli 500mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites. www.ernestoncology.com www.oncologymedicinesupplier.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Cabozantinib 40mg Tablet: Multi-Targeted Tyrosine Kinase Inhibition for Advanced Solid Tumors Are you searching for a reliable Cabozantinib 40mg Tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted therapies. We maintain a secure supply chain for London, Washington, Canberra, and Johannesburg, ensuring medications reach institutional pharmacies with 100% integrity. 1. Mechanism of Action: Multi-Pathway Inhibition Tyrosine Kinase Inhibition: It inhibits several receptor tyrosine kinases, including MET, VEGFR-1, -2, and -3, and AXL. Anti-Angiogenesis: By blocking VEGFR receptors, it prevents the tumor from forming new blood vessels needed for growth. Signal Interruption: It disrupts pathways involved in cancer cell survival, metastasis, and the development of drug resistance. 2. Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): Effective for kidney cancer, including as first-line therapy or after prior anti-angiogenic treatment. Hepatocellular Carcinoma (HCC): Used for liver cancer patients previously treated with sorafenib. Differentiated Thyroid Cancer (DTC): Specifically for patients with radioactive iodine-refractory thyroid cancer that has progressed. Medullary Thyroid Cancer (MTC): Utilized for progressive, metastatic thyroid cancer. 3. Administration and Clinical Handling Standard Dosing: The 40mg dose is often used in combination with immunotherapy (e.g., Nivolumab) or as a dose-adjusted monotherapy. Timing: Take on an empty stomach. Do not eat for at least 2 hours before and 1 hour after dosing. Consistency: Swallow tablets whole; do not crush, split, or chew. Dietary Restriction: Avoid grapefruit products, as they can dangerously increase drug levels in the blood. 4. Clinical Side Effects & Safety Monitoring Hypertension: Blood pressure must be monitored regularly; anti-hypertensive therapy is often required. Hand-Foot Skin Reaction (HFSR): Redness, swelling, and pain on palms/soles; early management is vital. Gastrointestinal Health: Risk of severe diarrhea, nausea, and stomatitis. Hemorrhage & Perforation: Patients must be monitored for signs of internal bleeding or GI perforations. Wound Healing: Treatment must be discontinued at least 3 weeks prior to elective surgery. 5. Why Source from Ernest Oncology? Verified Authenticity: Direct sourcing from high-integrity manufacturers with full batch-specific COA. Logistics Authority: Expert handling of international export regulations and cold-chain maintenance for the USA, UK, and Australia. Wholesale Solutions: Competitive bulk pricing for hospital groups and regional distributors. Regulatory Compliance: Shipments include GMP certificates and comprehensive B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Pemetrex Injection (Pemetrexed): Advanced Multi-Targeted Antifolate for Thoracic Oncology – Global Supply by Ernest Oncology In the precision-driven landscape of 2026 oncology, Pemetrex Injection (containing the active ingredient Pemetrexed) remains a foundational treatment for non-small cell lung cancer (NSCLC) and mesothelioma. As a multi-targeted antifolate, Pemetrex is designed to disrupt the metabolic pathways of malignant cells with high specificity. Its integration into first-line and maintenance protocols has redefined survival benchmarks for patients globally. Ernest Oncology, the specialized oncology division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We facilitate the secure, GMP-compliant international distribution of Pemetrex Injection to the UK (London), USA, Abu Dhabi (UAE), Australia, and South Africa via validated pharmaceutical logistics. What is Pemetrex Injection? Pemetrex is a sterile, lyophilized powder for intravenous infusion, typically available in strengths of 100 mg and 500 mg Vials. It is a chemically unique folate antimetabolite that targets multiple enzymes essential for cell replication. Primary Therapeutic Indications Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Used in combination with cisplatin for first-line treatment, and as a single agent for maintenance or second-line therapy. Malignant Pleural Mesothelioma: The gold-standard treatment, used in combination with cisplatin, for patients whose disease is unresectable or who are not candidates for surgery. Combination Therapy: Increasingly used in 2026 in triplet combinations with immunotherapy to maximize pathological complete response (pCR) rates. Technical Product Profile: Pemetrex (Pemetrexed) Feature Technical Specification Brand Name Pemetrex Active Ingredient Pemetrexed Disodium Pharmacological Class Antifolate Antimetabolite Available Strengths “100 mg, 500 mg Vials“ Manufacturer Leading GMP Indian Partners Dosage Form Lyophilized Powder for Reconstitution (IV Infusion) Storage 20°C to 25°C; Reconstituted solution is stable for up to 24 hours Mechanism of Action: Triple Enzyme Inhibition Pemetrex exerts its cytotoxic effect by disrupting the folate-dependent metabolic processes necessary for cell replication: Multi-Targeted Blockade: Unlike older antifolates, Pemetrex inhibits three key enzymes: Thymidylate Synthase (TS), Dihydrofolate Reductase (DHFR), and Glycinamide Ribonucleotide Formyltransferase (GARFT). DNA/RNA Deprivation: By shutting down these pathways, the drug prevents the synthesis of thymidine and purine nucleotides, effectively starving the cancer cell of the “building blocks“ needed for DNA synthesis. Selectivity: It shows a high affinity for non-squamous tumor cells, making it a highly specialized tool for specific NSCLC histologies. Clinical Administration & Safety Pre-medication Protocol: To reduce toxicity, patients must receive Folic Acid and Vitamin B12 supplementation starting prior to the first dose. Dexamethasone is also administered to prevent skin rashes. Renal Monitoring: Pemetrexed is primarily eliminated by the kidneys; therefore, calculating Creatinine Clearance (CrCl) is mandatory before every cycle. Hematologic Monitoring: Patients should be monitored for myelosuppression (primarily neutropenia and thrombocytopenia). Global Supply Chain: London, USA, UAE, Australia, & South Africa Ernest Oncology leverages India’s world-class pharmaceutical manufacturing to stabilize the global supply of Pemetrex. We ensure that B2B buyers receive products that meet the stringent 2026 quality benchmarks of international regulatory bodies. United Kingdom & London: Reliable supply to NHS Trusts and private oncology clinics in London via MHRA-compliant channels. United States: Bulk procurement options for specialized pharmacies, hospital systems, and oncology centers. Abu Dhabi & UAE: Priority shipping to the Middle East's premier medical cities and government healthcare authorities. Australia & South Africa: Strategic distribution to regional wholesalers, maintaining stable stock for national lung cancer programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of high-quality oncology injectables. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Pemnat Injection (Pemetrexed): Precision Antifolate Therapy for Lung Cancer – Global Supply by Ernest Oncology In the evolving landscape of 2026 thoracic oncology, Pemnat Injection (containing the active ingredient Pemetrexed) remains a foundational treatment for non-small cell lung cancer (NSCLC) and mesothelioma. As a multi-targeted antifolate, Pemnat is globally recognized for its ability to significantly improve survival outcomes when used in first-line, maintenance, and second-line settings. Its refined efficacy profile makes it a non-negotiable component of modern oncology protocols. Ernest Oncology, the specialized oncology division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We facilitate the secure, GMP-compliant international distribution of Pemnat Injection to the UK (London), USA, Abu Dhabi (UAE), Australia, and South Africa via validated pharmaceutical logistics. What is Pemnat Injection? (Mechanism & Clinical Indications) Pemnat is a sterile, lyophilized powder for intravenous infusion, typically available in strengths of 100 mg and 500 mg Vials. It is a chemically unique folate antimetabolite that targets multiple enzymes essential for cell replication. Primary Therapeutic Indications Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Used in combination with cisplatin for first-line treatment, and as a single agent for maintenance or second-line therapy. Malignant Pleural Mesothelioma: The gold-standard treatment, used in combination with cisplatin, for patients whose disease is unresectable or who are not candidates for curative surgery. Combination Therapy: Often utilized alongside immunotherapy agents (such as pembrolizumab) to enhance clinical response in advanced metastatic settings. Technical Product Profile: Pemnat (Pemetrexed) Feature Technical Specification Brand Name Pemnat Active Ingredient Pemetrexed Disodium Pharmacological Class Antifolate Antimetabolite Available Strengths “100 mg, 500 mg Vials“ Manufacturer “Leading GMP Indian Partners (e.g., Natco Pharma)“ Dosage Form Lyophilized Powder for Reconstitution (IV Infusion) Storage 20°C to 25°C; Reconstituted solution is stable for up to 24 hours Mechanism of Action: Triple Enzyme Inhibition Pemnat exerts its cytotoxic effect by disrupting the folate-dependent metabolic processes necessary for cell replication: Multi-Targeted Blockade: Unlike older antifolates, Pemnat inhibits three key enzymes: Thymidylate Synthase (TS), Dihydrofolate Reductase (DHFR), and Glycinamide Ribonucleotide Formyltransferase (GARFT). DNA/RNA Deprivation: By shutting down these pathways, the drug prevents the synthesis of thymidine and purine nucleotides, effectively starving the cancer cell of the “building blocks“ needed for DNA and RNA synthesis. Selectivity: It shows a high affinity for non-squamous tumor cells, making it a highly specialized tool for specific NSCLC histologies. Clinical Administration & Safety Pre-medication Protocol: To reduce toxicity, patients must receive Folic Acid and Vitamin B12 supplementation starting prior to the first dose. Dexamethasone is also administered to prevent skin rashes. Renal Monitoring: Pemetrexed is primarily eliminated by the kidneys; therefore, calculating Creatinine Clearance (CrCl) is mandatory before every cycle. Hematologic Monitoring: Patients should be monitored for myelosuppression (primarily neutropenia and thrombocytopenia). Global Supply Chain: London, USA, UAE, Australia, & South Africa Ernest Oncology leverages India’s world-class pharmaceutical manufacturing to stabilize the global supply of Pemnat. We ensure that B2B buyers receive products that meet the stringent 2026 quality benchmarks of international regulatory bodies. United Kingdom & London: Reliable supply to NHS Trusts and private oncology clinics in London via MHRA-compliant channels. United States: Bulk procurement options for specialized pharmacies, hospital systems, and oncology centers. Abu Dhabi & UAE: Priority shipping to the Middle East's premier medical cities and government healthcare authorities. Australia & South Africa: Strategic distribution to regional wholesalers, maintaining stable stock for national lung cancer programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of high-quality oncology injectables. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Alimta Injection (Pemetrexed): Precision Antifolate Therapy for Lung Cancer – Global Supply by Ernest Oncology In the evolving landscape of 2026 thoracic oncology, Alimta Injection (containing the active ingredient Pemetrexed) remains a foundational treatment for non-small cell lung cancer (NSCLC) and mesothelioma. As a multi-targeted antifolate, Alimta is globally recognized for its ability to significantly improve survival outcomes when used in first-line, maintenance, and second-line settings. Its refined efficacy profile makes it a non-negotiable component of modern oncology protocols. Ernest Oncology, the specialized oncology division of Ernest Pharmaceutical Pvt. Ltd., is a leading Exporter, Bulk Supplier, and Distributor from India. We facilitate the secure, GMP-compliant international distribution of Alimta Injection to the UK (London), USA, Abu Dhabi (UAE), Australia, and South Africa via validated pharmaceutical logistics. What is Alimta Injection? (Mechanism & Clinical Indications) Alimta is a sterile, lyophilized powder for intravenous infusion, typically available in strengths of 100 mg and 500 mg Vials. It is a chemically unique folate antimetabolite that targets multiple enzymes essential for cell replication. Primary Therapeutic Indications Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Used in combination with cisplatin for first-line treatment, and as a single agent for maintenance or second-line therapy. Malignant Pleural Mesothelioma: The gold-standard treatment, used in combination with cisplatin, for patients whose disease is unresectable or who are not candidates for curative surgery. Combination Therapy: Often utilized alongside immunotherapy agents (such as pembrolizumab) to enhance clinical response in advanced metastatic settings. Technical Product Profile: Alimta (Pemetrexed) Feature Technical Specification Brand Name Alimta Active Ingredient Pemetrexed Disodium Pharmacological Class Antifolate Antimetabolite Available Strengths “100 mg, 500 mg Vials“ Manufacturer Eli Lilly / Leading WHO-GMP Indian Partners Dosage Form Lyophilized Powder for Reconstitution (IV Infusion) Storage 20°C to 25°C; Reconstituted solution is stable for up to 24 hours Mechanism of Action: Triple Enzyme Inhibition Alimta exerts its cytotoxic effect by disrupting the folate-dependent metabolic processes necessary for cell replication: Multi-Targeted Blockade: Unlike older antifolates, Alimta inhibits three key enzymes: Thymidylate Synthase (TS), Dihydrofolate Reductase (DHFR), and Glycinamide Ribonucleotide Formyltransferase (GARFT). DNA/RNA Deprivation: By shutting down these pathways, the drug prevents the synthesis of thymidine and purine nucleotides, effectively starving the cancer cell of the “building blocks“ needed for DNA and RNA synthesis. Selectivity: It shows a high affinity for non-squamous tumor cells, making it a highly specialized tool for specific NSCLC histologies. Clinical Administration & Safety Pre-medication Protocol: To reduce toxicity, patients must receive Folic Acid and Vitamin B12 supplementation starting prior to the first dose. Dexamethasone is also administered to prevent skin rashes. Renal Monitoring: Pemetrexed is primarily eliminated by the kidneys; therefore, calculating Creatinine Clearance (CrCl) is mandatory before every cycle. Hematologic Monitoring: Patients should be monitored for myelosuppression (primarily neutropenia and thrombocytopenia). Global Supply Chain: London, USA, UAE, Australia, & South Africa Ernest Oncology leverages India’s world-class pharmaceutical manufacturing to stabilize the global supply of Alimta. We ensure that B2B buyers receive products that meet the stringent 2026 quality benchmarks of international regulatory bodies. United Kingdom & London: Reliable supply to NHS Trusts and private oncology clinics in London via MHRA-compliant channels. United States: Bulk procurement options for specialized pharmacies, hospital systems, and oncology centers. Abu Dhabi & UAE: Priority shipping to the Middle East's premier medical cities and government healthcare authorities. Australia & South Africa: Strategic distribution to regional wholesalers, maintaining stable stock for national lung cancer programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of high-quality oncology injectables. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383

Biotrexate 50mg Injection (Methotrexate) – Chemotherapy & Immunosuppressant Medicine | Global Supplier & Exporter Biotrexate 50mg Injection contains Methotrexate, a chemotherapy and immunosuppressant medicine widely used in the treatment of various cancers and autoimmune diseases. Methotrexate belongs to a class of medicines known as antimetabolites, which work by inhibiting the growth and multiplication of rapidly dividing cells such as cancer cells. Biotrexate Injection is commonly prescribed for the treatment of leukemia, lymphoma, breast cancer, osteosarcoma, and certain autoimmune disorders such as rheumatoid arthritis and psoriasis. It is an essential medication in many chemotherapy protocols and immunotherapy treatments. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Biotrexate 50mg Injection to hospitals, oncology clinics, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Biotrexate 50mg Injection Generic Name: Methotrexate Strength: 50 mg Form: Injection / Vial Drug Class: Antimetabolite Chemotherapy Agent Manufacturer: Biochem Pharmaceutical Industries Ltd. Packaging: 1 Vial Route of Administration: Intravenous, Intramuscular, or Subcutaneous Injection Mechanism of Action Biotrexate contains Methotrexate, which works by inhibiting the enzyme dihydrofolate reductase (DHFR). This action blocks the production of DNA, RNA, and proteins required for cell growth and division, thereby preventing cancer cells and abnormal immune cells from multiplying. Uses of Biotrexate 50mg Injection Biotrexate Injection is used in the treatment of: Leukemia Non-Hodgkin’s Lymphoma Breast Cancer Osteosarcoma Rheumatoid Arthritis Psoriasis Other autoimmune diseases Benefits Effective chemotherapy drug for multiple cancers Helps control autoimmune disease activity Prevents rapid cell division in cancer cells Widely used in combination chemotherapy regimens Improves treatment outcomes in oncology therapy Dosage & Administration Biotrexate 50mg Injection is administered through intravenous, intramuscular, or subcutaneous injection under the supervision of a qualified healthcare professional in a hospital or oncology center. The dosage depends on the patient’s condition and treatment protocol. Possible Side Effects Some patients may experience: Nausea and vomiting Mouth sores Fatigue Low blood cell counts Liver function changes Patients should be monitored regularly during treatment. Storage Instructions Store in a cool and dry place Protect from light Keep out of reach of children Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and distributor of oncology and specialty medicines. We supply authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Genuine pharmaceutical products GMP-certified sourcing Competitive wholesale pricing Reliable international shipping (DHL / Aramex / FedEx) Export documentation, including COA, MSDS, invoice, and Packing List 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Reditux 500mg Injection – Rituximab | Lymphoma & Leukemia Treatment | Global Supplier & Exporter Reditux 500mg Injection contains Rituximab, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune disorders. It works by targeting the CD20 protein present on B-cells, allowing the immune system to destroy abnormal or cancerous B-cells. Reditux is widely used for the treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis. It may also be prescribed for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA). The medicine is typically administered in combination with chemotherapy or immunotherapy protocols to improve treatment effectiveness. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Reditux 500mg Injection to hospitals, oncology centers, pharmacies, and pharmaceutical distributors worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Reditux 500mg Injection Generic Name: Rituximab Strength: 500 mg Form: Injection / Vial Drug Class: Monoclonal Antibody Manufacturer: Dr. Reddy’s Laboratories Ltd. Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Reditux contains Rituximab, which is designed to target the CD20 antigen found on B-lymphocytes. By binding to CD20, it activates the immune system to destroy abnormal B-cells responsible for certain cancers and autoimmune diseases. This targeted therapy helps slow disease progression and improves treatment outcomes. Uses of Reditux 500mg Injection Reditux Injection is used in the treatment of: Non-Hodgkin’s Lymphoma Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis Granulomatosis with Polyangiitis Microscopic Polyangiitis Other B-cell related autoimmune disorders Benefits Targeted monoclonal antibody therapy Effective treatment for lymphoma and leukemia Helps control autoimmune immune-system disorders Used with chemotherapy for better outcomes Helps destroy abnormal B-cells in the body Dosage & Administration Reditux 500mg Injection is administered through intravenous infusion by a trained healthcare professional in a hospital or oncology clinic. The dosage and frequency depend on the patient’s medical condition, body weight, and treatment protocol. Possible Side Effects Some patients may experience: Fever or chills Infusion-related reactions Fatigue Low white blood cell count Headache or nausea Patients should be monitored closely during treatment. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and supplier of oncology and specialty medicines. We supply authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Genuine oncology medicines GMP certified sourcing Competitive wholesale pricing Reliable worldwide shipping (DHL / Aramex / FedEx) Export documentation including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Rituxirel 500mg Injection – Rituximab | Targeted Cancer & Autoimmune Therapy Supplier | Ernest Oncology Rituxirel 500mg Injection contains Rituximab, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune diseases. It works by targeting the CD20 protein found on B-cells, helping the immune system destroy abnormal or cancerous B-cells. Rituxirel is widely used in the treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis. It is commonly administered along with chemotherapy or other immunotherapy treatments to improve therapeutic outcomes. Ernest Oncology – Pharmaceutical Exporter from India supplies genuine Rituxirel 500mg Injection to hospitals, oncology centers, distributors, and pharmacies worldwide with competitive wholesale pricing and reliable international delivery. Product Information Product Name: Rituxirel 500mg Injection Generic Name: Rituximab Strength: 500 mg Form: Injection / Vial Drug Class: Monoclonal Antibody Manufacturer: Reliance Life Sciences Packaging: 1 Vial Route of Administration: Intravenous Infusion Mechanism of Action Rituxirel contains Rituximab, a monoclonal antibody that targets the CD20 antigen present on B-lymphocytes. By binding to CD20, Rituximab helps the immune system destroy abnormal or malignant B-cells, thereby reducing tumor growth and controlling autoimmune activity. Uses of Rituxirel 500mg Injection Rituxirel Injection is used for the treatment of: Non-Hodgkin’s Lymphoma Chronic Lymphocytic Leukemia (CLL) Rheumatoid Arthritis Granulomatosis with Polyangiitis (GPA) Microscopic Polyangiitis (MPA) Certain autoimmune disorders Benefits Targeted therapy for B-cell cancers Helps destroy abnormal immune cells Effective treatment for lymphoma and leukemia Used in combination with chemotherapy Improves clinical outcomes in autoimmune diseases Dosage & Administration Rituxirel 500mg Injection is administered by intravenous infusion under the supervision of a qualified healthcare professional in a hospital or oncology clinic. The dosage and treatment schedule depend on the patient’s condition, body weight, and medical history. Possible Side Effects Some patients may experience: Fever or chills Infusion reactions Nausea or fatigue Low blood cell counts Headache Patients should be monitored closely during treatment to manage potential side effects. Storage Instructions Store at 2°C to 8°C (Refrigerated) Protect from light Do not freeze Global Export & Bulk Supply Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. is a trusted global exporter and distributor of oncology and specialty medicines. We provide authentic pharmaceutical products with complete export documentation and worldwide delivery. We export medicines to: USA | UK | UAE | Saudi Arabia | Singapore | Australia | Thailand | Africa | Europe | Latin America Why Choose Ernest Oncology? Trusted global pharmaceutical exporter from India GMP certified sourcing Competitive wholesale pricing Reliable international shipping (DHL / Aramex / FedEx) Export documentation including COA, MSDS, Invoice, Packing List 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Mabtas 500mg Injection (Rituximab) – Global Supplier & Exporter | Ernest Oncology Mabtas 500mg Injection Mabtas 500mg Injection contains Rituximab, a monoclonal antibody medicine widely used for the treatment of blood cancers and certain autoimmune diseases. It works by targeting the CD20 protein found on B-lymphocytes, helping the immune system destroy abnormal cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines and biologic therapies, supplying Mabtas 500mg injections to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Mabtas 500mg Injection? Mabtas Injection is a targeted biologic therapy designed to treat cancers that affect B-cells, a type of white blood cell. The active ingredient Rituximab binds to the CD20 antigen present on B-cells and triggers immune-mediated destruction of cancerous cells. It is also used to treat certain autoimmune diseases by reducing abnormal immune responses. Mechanism of Action Rituximab works by targeting the CD20 antigen on B-cells. Its mechanism includes: • Binding to CD20 proteins on B-lymphocytes • Activating immune-mediated destruction of abnormal cells • Inducing apoptosis (programmed cell death) in cancer cells • Reducing abnormal immune system activity This targeted therapy helps eliminate cancerous B-cells and control disease progression. Indications Mabtas 500mg Injection is used for the treatment of: • Non-Hodgkin’s Lymphoma (NHL) • Chronic Lymphocytic Leukemia (CLL) • Rheumatoid Arthritis • Granulomatosis with Polyangiitis (GPA) • Microscopic Polyangiitis (MPA) It may be used alone or in combination with chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • Administered as intravenous infusion • Dosage based on body surface area and treatment protocol • Treatment schedule determined by the oncologist or physician Infusion should be given in a hospital or clinical setting under medical supervision. Key Benefits of Mabtas 500mg Injection ✔ Targeted monoclonal antibody therapy ✔ Effective treatment for blood cancers ✔ Helps eliminate abnormal B-cells ✔ Used in both oncology and autoimmune disease therapy ✔ Proven treatment option in modern immunotherapy Possible Side Effects Some patients may experience: • Infusion reactions • Fever or chills • Fatigue • Nausea • Low white blood cell count • Increased risk of infections Patients should be monitored during infusion therapy. Product Specifications Product Name: Mabtas Generic Name: Rituximab Strength: 500 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Monoclonal Antibody Packaging: Vial Storage: Store in refrigerator (2°C – 8°C) Ernest Oncology supplies Mabtas 500mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Website www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383